Article Versions Notes

Wischmann P, Stern M, Florea D-I, Neudorf L, Haddad Y, Kramser N, Schillings M, Baasen S, Schremmer J, Heiss C, et al. Three-Year Safety and Efficacy of Endovascular Treatment of Common Femoral Artery in 150 PAD Patients. Biomedicines. 2024; 12(10):2213. https://doi.org/10.3390/biomedicines12102213

Wischmann, Patricia, Manuel Stern, David-Ioan Florea, Luise Neudorf, Yassine Haddad, Nicolas Kramser, Miriam Schillings, Sven Baasen, Johanna Schremmer, Christian Heiss, and et al. 2024. "Three-Year Safety and Efficacy of Endovascular Treatment of Common Femoral Artery in 150 PAD Patients" Biomedicines 12, no. 10: 2213. https://doi.org/10.3390/biomedicines12102213

Wischmann, P., Stern, M., Florea, D.-I., Neudorf, L., Haddad, Y., Kramser, N., Schillings, M., Baasen, S., Schremmer, J., Heiss, C., Kelm, M., & Busch, L. (2024). Three-Year Safety and Efficacy of Endovascular Treatment of Common Femoral Artery in 150 PAD Patients. Biomedicines, 12(10), 2213. https://doi.org/10.3390/biomedicines12102213